Delivery Order SPE2DB22D3501-SPE2DB25FXM23
Award Date 9/22/25
Potential Completion Date 10/14/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $12,446.16 to AmerisourceBergen Drug Corp for the supply of Lazcluze 240 mg tablets (30-count units) on July 16, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $12,449.18 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Lazcluze 80 mg, with performance at the company's headquarters in Conshohocken, Pennsylvania, and completion targeted for September 30, 2025. This non-set-aside contract was competitively awarded on September 9, 2025, under firm fixed pricing terms and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. This delivery order is executed...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on July 14, 2025, for the supply of Lazcluze 240 mg tablets in quantities of 30 units. This firm fixed price delivery order carries a ceiling value of $12,446.16 and is scheduled for completion by August 4, 2025. The award was made through open competition with no set-aside designation, and the pharmaceutical products will be delivered to the contractor's location in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Lazicluze 240 mg tablets (30-count units) with a ceiling value of $12,446.16. This firm fixed-price delivery order, with an ultimate completion date of July 9, 2025, represents a non-competitive set-aside transaction executed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, a major...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $12,446.16 firm fixed-price delivery order is for the supply of LAZCLUZE 240 MG TABLET 30S, a medical product, with a completion date of July 10, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,446.16 Firm Fixed Price delivery order contract is for the supply of 4568726454 ! LAZCLUZE 240 MG TABLET 30S. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and the place of performance is Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $4,414.79 delivery order to AmerisourceBergen Drug Corp for Qualipla 60 mg tablets (30-count packages) with a firm fixed price contract type. The award was made on September 23, 2025, with an ultimate completion date of September 24, 2025, and the pharmaceutical product will be delivered to Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet...
- On September 17, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at approximately $24,956 to AmerisourceBergen Drug Corp for the supply of Loqtorzi 240 mg/6 ml vials. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The delivery order is scheduled for completion by October 8, 2025,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order contract valued at $45,231.48 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's Corporate Office location in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $23,237.52 to AmerisourceBergen Drug Corp on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price delivery order, issued under a competitively awarded contract with no set-aside designation, will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...